Braveheart Bio, Inc. (NasdaqGM: BRVE)
Health Care · Pharmaceuticals · US
$19.49
-0.66% today · -34.6% 1Y
Public summary
A free snapshot of Braveheart Bio, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Braveheart Bio, Inc. (NasdaqGM: BRVE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.59B and employs 49 people.
Over the last twelve months the share price has lost 34.6%, trading between 17.42 and 32.00.
Tweenvest scores Braveheart Bio, Inc. across four factors: quality 78/100, value 100/100. Its strongest factor is value.
BRVE price history
Key figures
- Market cap
- $1.59B
- Revenue (TTM)
- —
- P/E
- -16.78
- EPS
- -8.20
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $32.00
- 52-week low
- $17.42
- Avg volume (3M)
- —
- Shares outstanding
- 81.63M
- Employees
- 49
- Next earnings
- —
About Braveheart Bio, Inc.
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
- ISIN
- US10567X1019
- Founded
- 2024
- Listed since
- Aug 6, 2026
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jubilant Pharmova LimitedBSE: 530019 | $1.62B | Rs965.10 | -1.74% |
| Mayinglong Pharmaceutical Group Co., Ltd.SHSE: 600993 | $1.61B | CN¥24.89 | +2.22% |
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.60B | CN¥7.97 | -1.24% |
| Tibet Cheezheng Tibetan Medicine Co., Ltd.SZSE: 002287 | $1.60B | CN¥18.79 | +0.54% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd.SHSE: 600572 | $1.57B | CN¥4.12 | -0.48% |
| Fujian Haixi Pharmaceuticals Co., Ltd.SEHK: 2637 | $1.57B | HK$156.00 | -0.32% |
| Vigonvita Life Sciences Co., Ltd.SEHK: 2630 | $1.55B | HK$72.65 | -3.13% |
| Marksans Pharma LimitedNSEI: MARKSANS | $1.53B | Rs318.50 | -0.47% |